Susceptibility to Vibrio cholerae Infection in a Cohort of Household Contacts of Patients with Cholera in Bangladesh by Chowdhury, Fahima et al.
 
Susceptibility to Vibrio cholerae Infection in a Cohort of Household
Contacts of Patients with Cholera in Bangladesh
 
 
(Article begins on next page)
The Harvard community has made this article openly available.
Please share how this access benefits you. Your story matters.
Citation Harris, Jason B., Regina C. LaRocque, Fahima Chowdhury,
Ashraful I. Khan, Tanya Logvinenko, Abu S. G. Faruque, Edward
T. Ryan, Firdausi Qadri, and Stephen B. Calderwood. 2008.
Susceptibility to Vibrio cholerae infection in a cohort of household
contacts of patients with cholera in Bangladesh. PLoS Neglected
Tropical Diseases 2(4): e221.
Published Version doi://10.1371/journal.pntd.0000221
Accessed February 19, 2015 8:33:58 AM EST
Citable Link http://nrs.harvard.edu/urn-3:HUL.InstRepos:7349729
Terms of Use This article was downloaded from Harvard University's DASH
repository, and is made available under the terms and conditions
applicable to Other Posted Material, as set forth at
http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-
use#LAASusceptibility to Vibrio cholerae Infection in a Cohort of
Household Contacts of Patients with Cholera in
Bangladesh
Jason B. Harris
1,2*, Regina C. LaRocque
1,3, Fahima Chowdhury
4, Ashraful I. Khan
4, Tanya Logvinenko
5,
Abu S. G. Faruque
4, Edward T. Ryan
1,3,6, Firdausi Qadri
4, Stephen B. Calderwood
1,3,7
1Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, United States of America, 2Department of Pediatrics, Massachusetts General
Hospital, Boston, Massachusetts, United States of America, 3Department of Medicine, Harvard Medical School, Boston, Massachusetts, United States of America,
4International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh, 5Department of Biostatistics, Massachusetts General Hospital, Boston, Massachusetts, United
States of America, 6Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts, United States of America, 7Department
of Microbiology and Molecular Genetics, Harvard Medical School, Boston, Massachusetts, United States of America
Abstract
Background: Despite recent progress in understanding the molecular basis of Vibrio cholerae pathogenesis, there is
relatively little knowledge of the factors that determine the variability in human susceptibility to V. cholerae infection.
Methods and Findings: We performed an observational study of a cohort of household contacts of cholera patients in
Bangladesh, and compared the baseline characteristics of household members who went on to develop culture-positive V.
cholerae infection with individuals who did not develop infection. Although the vibriocidal antibody is the only previously
described immunologic marker associated with protection from V. cholerae infection, we found that levels of serum IgA
specific to three V. cholerae antigens—the B subunit of cholera toxin, lipopolysaccharide, and TcpA, the major component
of the toxin–co-regulated pilus—also predicted protection in household contacts of patients infected with V. cholerae O1,
the current predominant cause of cholera. Circulating IgA antibodies to TcpA were also associated with protection from V.
cholerae O139 infection. In contrast, there was no association between serum IgG antibodies specific to these three antigens
and protection from infection with either serogroup. We also found evidence that host genetic characteristics and serum
retinol levels modify susceptibility to V. cholerae infection.
Conclusions: Our observation that levels of serum IgA (but not serum IgG) directed at certain V. cholerae antigens are
associated with protection from infection underscores the need to better understand anti–V. cholerae immunity at the
mucosal surface. Furthermore, our data suggest that susceptibility to V. cholerae infection is determined by a combination
of immunologic, nutritional, and genetic characteristics; additional factors that influence susceptibility to cholera remain
unidentified.
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Introduction
Vibrio cholerae causes a spectrum of infection in humans ranging
from asymptomatic colonization to severe secretory diarrhea. V.
cholerae is differentiated serologically by the O antigen of its
lipopolysaccharide (LPS); the vast majority of human cholera is
caused by the O1 and O139 serogroups. The O1 serogroup of V.
cholerae is classified into two biotypes (classical and El Tor), and two
major serotypes (Inaba and Ogawa) [1]. In the 1960s, the V.
cholerae O1 El Tor biotype emerged as a major cause of cholera,
ultimately replacing the classical biotype. In 1992, the V. cholerae
O139 serogroup first appeared, and after briefly predominating in
South Asia, now persists in this region, but at much lower levels
than V. cholerae O1 El Tor.
Although absent from the view of most resource-rich nations,
the global impact of V. cholerae infection remains enormous.
Cholera is vastly underreported, but it is estimated that there are
over one million cases of cholera annually, with more than
100,000 deaths [2]. According to the WHO, there is an urgent
need for cholera vaccines that provide durable protection,
particularly among children less than 5 years of age in developing
countries [2]. One limitation to the development of effective
vaccination programs for cholera is that the factors that determine
human susceptibility to V. cholerae remain poorly defined.
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responses that are protective against subsequent disease. Volunteer
studies in non-endemic settings have demonstrated that infection
with classical biotype V. cholerae O1 provides 100% protection from
subsequent challenge with a classical biotype strain, while infection
with the El Tor biotype of V. cholerae O1 provides 90% protection
from subsequent challenge with an El Tor strain. This protection
lasts at least 3 years in volunteer studies [3]. In an endemic area,
an initial episode of El Tor cholera reduces the risk of a second
clinically apparent infection by 90% over the next several years
[4].
The best-studied correlate of immunity to V. cholerae is the serum
vibriocidal antibody, a complement-fixing bacteriocidal antibody.
Seroepidemiologic studies in endemic areas have shown that
vibriocidal antibody titers increase with age and correlate with
protection from cholera [5,6]. However, there is no threshold
vibriocidal antibody titer above which complete protection from
infection is achieved, and the vibriocidal antibody may be a
surrogate marker for an undetermined protective immune
response at the mucosal surface [7].
Although a major component of the vibriocidal antibody is
directed against serotype specific LPS, levels of serum LPS-specific
immunoglobulin G (IgG) antibody have not been found to
correlate with protection from cholera in humans [5]. A portion of
the vibriciodal antibody may also be directed against V. cholerae
outer membrane proteins [8]. Antitoxin immunity is primarily
directed at the B subunit of cholera toxin (CTB); however serum
IgG-antibodies to CTB have not been found to correlate with
protection from cholera [5], and toxin-based vaccines confer only
transient protection [9]. Robust mucosal and systemic humoral
responses to TcpA, the major subunit of the toxin-coregulated
pilus (TCP), a type IV pilus that is required for intestinal
colonization, have recently been demonstrated in patients with
cholera [10], but it is unknown whether these responses are
associated with protection from disease.
In addition to adaptive immune responses, innate host
characteristics may also influence the outcome of an individual’s
exposure to V. cholerae. Multiple case-control studies in cholera
endemic areas have demonstrated that individuals with blood
group O are at increased risk of hospitalization with cholera, and it
has been hypothesized that V. cholerae infection may have selected
for the low prevalence of the O blood group in the Ganges Delta
region, a historic and current global epicenter of cholera [11].
Other genetic or innate immune factors may also influence
susceptibility to cholera. For example, studies of duodenal biopsies
obtained from patients with cholera demonstrate recruitment of
neutrophils to the intestinal epithelium during acute infection [12],
and also reveal increased expression of broad classes of innate
immune effectors, including lactoferrin and other antibacterial
proteins [13], suggesting further potential sources of genetic
variability that might contribute to susceptibility to cholera.
The nutritional status of the host may also affect susceptibility to
diarrheal diseases such as cholera, by influencing both innate and
adaptive immunity. The micronutrients zinc and vitamin A play
central roles in mucosal immunity, and when given in community-
based supplementation programs, may reduce the incidence and
morbidity of diarrheal diseases [14]. Although zinc supplementa-
tion in children has been found to modify adaptive immune
responses to V. cholerae [15,16], there are no prior studies
demonstrating a specific association between baseline nutritional
characteristics and the risk of V. cholerae infection in individuals.
Here, we present the results of a prospective, observational
study aimed at identifying host factors that are associated with V.
cholerae infection within households in a cholera-endemic setting.
Our results may be relevant to the design and evaluation of more
effective cholera vaccines for use in resource-poor areas of the
world.
Methods
Study design and subject enrollment
The hospital at the Clinical Research and Service Centre
(CRSC) of the International Centre for Diarrhoeal Disease
Research, Bangladesh (ICDDR,B) provides care for more than
100,000 patients annually, including approximately 10,000 to
20,000 with cholera, the majority of whom are residents of Dhaka
city. Index cases presenting to the hospital with severe acute
watery diarrhea were eligible for inclusion in this study if their
stool cultures were subsequently positive for V. cholerae, if they were
older than 6 months, and if they were without significant co-
morbid conditions. Upon presentation of the index case, a field
team discussed enrollment with household contacts of the index
case, and consenting household contacts were then enrolled into
the study immediately upon culture confirmation of the index case
(within 24 hours of presentation of the index case). Household
contacts were defined as individuals who shared the same cooking
pot for three or more days. Blood specimens for ABO typing,
baseline vibriocidal titers, and baseline anti-LPS, anti-CTB and
anti-TcpA antibody levels were immediately collected from
consenting household contacts upon enrollment. The field team
visited household contacts on each of the next six days, and again
on days 14 and 21. During these visits, contacts were questioned
about diarrheal symptoms, and rectal swabs were obtained for V.
cholerae culture. Follow-up blood samples for vibriocidal antibody
titers were obtained from contacts on study days 7 and 21. All
patients designated as having completed follow-up had serum
successfully obtained at baseline and day 21, and 98% of the
interim field visits resulted in collection of clinical data and rectal
swabs.
Household contacts were excluded from the analysis if they did
not complete 21 days of follow-up. Household contacts were also
independently excluded from the analysis of their baseline
immunologic characteristics if they had symptoms of diarrhea
during the week preceding enrollment, if they had a positive rectal
swab culture for V. cholerae on enrollment into the study, or if they
Author Summary
Vibrio cholerae is the bacterium that causes cholera, a
severe form of diarrhea that leads to rapid and potentially
fatal dehydration when the infection is not treated
promptly. Cholera remains an important cause of diarrhea
globally, and V. cholerae continues to cause major
epidemics in the most vulnerable populations. Although
there have been recent discoveries about how the
bacterium adapts to the human intestine and causes
diarrhea, there is little understanding of why some people
are protected from infection with V. cholerae. This article
describes several factors that are associated with the risk of
developing V. cholerae infection among people living in
the same household with a patient with severe cholera
who are at high risk of contracting the infection. One of
the findings is that IgA antibodies, a type of antibody
associated with immunity at mucosal surfaces such as the
intestine, that target several components of the bacteria
are associated with immunity to V. cholerae infection. This
article also describes genetic and nutritional factors that
additionally influence susceptibility to V. cholerae infection.
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did not correspond to that of the index case.
Informed consent for participation in this research was obtained
from participants or their guardians. The human experimentation
guidelines of the U.S. Department of Health and Human Services
were followed in the conduct of this research. Approval for this
human study was obtained from the Institutional Review Board of
the Massachusetts General Hospital and the Research and the
Ethical Review Committees of the ICDDR,B.
Confirmation of bacterial strains
All index cases of cholera were confirmed by culturing stool for
V. cholerae on taurocholate-tellurite-gelatin agar (TTGA). After
overnight incubation of plates, serological confirmation of
suspected V. cholerae colonies was carried out by slide agglutination
[17,18]. Rectal swab specimens from household contacts were
collected in Cary-Blair transport media for subsequent plating on
TTGA and colony identification as above. V. cholerae was the only
pathogen for which microbiologic screening was carried out
during the 21 day follow-up period.
Immunologic and other laboratory assays
Vibriocidal antibody assays were performed with methodology
previously described, using guinea pig complement and the
homologous serogroup/type of V. cholerae O1 El Tor Ogawa
(strain 25049), V. cholerae O1 El Tor Inaba (strain T-19479), or V.
cholerae O139 (strain 4260B) [19]. Heat-inactivated serum was
diluted 5-fold, and serial 2 fold dilutions were assayed, with the
vibriocidal titer defined as the reciprocal of the highest serum
dilution resulting in greater than 50% reduction of the O.D. 600
when compared to control wells without serum. Positive and
negative control sera from infected and non-infected individuals
were used to ensure consistency across plates. The concentrations
of complement and bacteria have been separately optimized for
determining the vibriocidal antibody responses to V. cholerae O1
and V. cholerae O139 [19].
Serum and fecal antibodies specific to CTB, LPS, and TcpA
were measured by kinetic ELISAs using methods described
previously [10,20]. 96-well microtiter plates were coated with
either purified LPS (250 ng/well), sequentially with GM1
ganglioside (100 ng/well) followed by recombinant CTB (50 ng/
well) (gifts of A.M. Svennerholm), or with recombinant TcpA
(150 ng/well) [10]. Serogroup/type-specific LPS was derived from
the same strains used in the vibriocidal assay by hot-phenol
extraction, followed by proteinase, DNAse and RNAse treatment.
Plates were incubated with diluted patient sera (1:50 for LPS
ELISA, 1:100 for TCP, and 1:200 for CTB), washed, and
horseradish peroxidase-conjugated secondary antibodies to either
human IgG or IgA were applied (Jackson Laboratories, Bar
Harbor, Maine). Plates were developed using 0.1% ortho-
phenylene diamine (Sigma, St. Louis, Missouri) in 0.1 M sodium
citrate buffer with 0.1% hydrogen peroxide, and optical densities
(OD) were read kinetically at 450 nm for 5 minutes at 19-s
intervals. ELISA data were normalized across plates using control
serum derived from previously infected patients. Antigen specific-
IgA in fecal extracts were expressed as a fraction of total IgA in
fecal extracts, which was determined by ELISA using an IgA
standard (1 mg/ml) derived from human colostrum, as described
previously [20].
Serum retinol levels were assayed by high-performance liquid
chromatography, and serum zinc levels were assayed by atomic
absorption spectrophotometer [16].
Definition of outcomes in household contacts
Among household contacts, definite V. cholerae infection was
defined as a positive rectal swab culture for V. cholerae during the
21 days of follow-up. Possible infection was defined as a four-fold
or greater change in the serum vibriocidal antibody titer and/or
the development of diarrheal symptoms in the absence of detection
of V. cholerae in serial rectal swab cultures. The absence of infection
was defined as no positive culture for V. cholerae, no significant
changes in vibriocidal antibody titer, and no symptoms of
diarrhea. Symptomatic V. cholerae infection was defined as a
positive culture that occurred in association with diarrheal
symptoms (3 or more loose stools per day) within 72 hours of
developing the positive culture, and asymptomatic infection was
defined as a positive culture in the absence of diarrheal symptoms.
Statistical analyses
Analyses were performed using Stata version 9.0 (Stata
Corporation, Inc., College Station, Texas), and SAS version 9.1
(SAS Institute Inc, Cary, North Carolina). Characteristics of the
definitely infected household contacts were compared with
characteristics of the contacts with no evidence of infection with
logistic regression using generalized estimating equations, with an
exchangeable correlation matrix, and the reported odds ratios and
p values were adjusted for clustering based on household [21]. A
multivariate analysis of baseline immunologic characteristics,
including age, vibriocidal antibody, and serum anti-CTB, LPS,
and TCP IgG and IgA antibodies, was performed with a logistic
regression model clustered by household using generalized
estimating equations, with the final model determined based on
forward selection with a predetermined cutoff criteria of p#0.05
for inclusion in the model. Odds ratios (OR) are reported in the
text and tables with 95% confidence intervals (CI), and all
reported p values are two-tailed.
Results
Description of the cohort of household contacts
A total of 1077 household contacts of 396 index patients with
cholera were enrolled in the study between January 2001 and May
2006. 944 contacts completed 21 days of observation. Of the
household contacts that completed follow-up, there were 782
contacts of 304 index patients with cholera due to V. cholerae O1,
and 162 contacts of 57 index patients with V. cholerae O139.
Outcomes were defined by whether the household contacts
developed diarrhea, had a four-fold change in vibriocidal antibody
titer, or had a positive rectal swab for V. cholerae and are shown in
Table 1. Of the 944 contacts that completed the observation
period, 202 developed definite V. cholerae infection, defined as a
positive rectal swab culture (21%), and of those, 127 (62%)
developed diarrhea within 72 hours of their positive culture.
As described above, an additional subset of 229 of the 944
household contacts that completed the 21 days of observation
were excluded from the analysis of baseline immunologic
characteristics; this included 206 contacts who had diarrhea the
week prior to enrollment or a positive rectal swab upon
enrollment, and 23 contacts who developed infection with a V.
cholerae serotype/group that did not match the index case. None of
the household contacts required hospitalization or intravenous
hydration, although symptomatic individuals were treated prompt-
ly with antibiotics and home oral rehydration therapy as needed.
Age, gender and probability of infection with V. cholerae
Among household contacts of index cases infected with V.
cholerae O1, age was inversely related to the probability of
Susceptibility to Vibrio cholerae
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significant association between age and the probability of infection
with V. cholerae O139 was found (p=0.6).
The household contacts with the highest risk of V. cholerae O1
infection were young children. In children 5 years of age or
younger, the odds of developing infection with V. cholerae O1 were
2.7 times that of older individuals (P,0.001, 95% CI 1.61–4.49).
Children 5 years or younger also had a higher likelihood of
developing symptomatic illness if infected with either serogroup
(OR=2.7, P=0.03, 95% CI 1.10–7.43). No association between
gender and susceptibility to infection with V. cholerae of either
serogroup was found.
Immunologic markers and probability of infection with V.
cholerae
We assessed the association between a number of baseline
immunologic markers and risk of V. cholerae infection in this cohort
of household contacts. Associations between serologic markers and
the risk of infection are listed in Table 2. As described previously,
baseline vibriocidal antibody titer predicted protection from
subsequent infection with V. cholerae O1 (OR 0.82 for each
doubling of titer, 95% CI 0.74–0.92) but not from V. cholerae O139
(OR 0.97, 95% CI 0.82–1.15) [7]. However, the baseline
vibriocidal titer did not predict the risk of developing symptomatic
illness among those who were infected with V. cholerae O1 (OR
0.90, 95% CI 0.75–1.07).
A novel finding in our study was that V. cholerae antigen-specific
serum IgA levels predicted an individual’s susceptibility to V.
cholerae infection. As with the vibriocidal antibody, higher serum
levels of LPS-specific IgA were associated with protection from
infection with V. cholerae O1, but not with V. cholerae O139. CTB-
specific serum IgA levels were associated with protection from
infection with both the O1 and O139 serogroups (the ORs were
equivalent), but this finding only reached statistical significance for
V. cholerae O1 infection. TcpA-specific IgA levels were associated
with significant protection against both O1 and O139 serogroups.
In contrast with serum IgA results, there were no associations
between serum LPS, CTB, or TcpA-specific IgG and outcomes in
household contacts.
In a smaller subset of our cohort of household contacts, we also
evaluated CTB and LPS- specific IgA levels in fecal extracts. This
analysis included 282 contacts that completed 21 days of follow-up
prior to June 2002. Fecal levels of antigen specific IgA were not
significantly correlated with serum IgA levels to the same antigen.
Levels of fecal CTB IgA were not significantly associated with the
risk of infection with V. cholerae, or with the risk of diarrhea in
infected individuals. However, higher levels of LPS-specific
antibodies in feces at baseline were significantly associated with
a lower likelihood of developing symptomatic disease in individuals
infected with V. cholerae O1 (OR 0.58 per two-fold increase,
p=0.027, 95% CI 0.36–0.94).
To explore potential confounding between immunologic
markers that were associated with protection from infection with
V. cholerae O1 in the univariate analysis, we performed a stepwise,
multivariate logistic regression analysis using generalized estimat-
ing equations. In the final model derived, three variables – age,
baseline vibriocidal titer, and baseline serum CTB-IgA titer – were
significant independent predictors of susceptibility to infection with
V. cholerae O1 (Table 3). Serum anti-TcpA and anti-LPS IgA
antibodies were more highly correlated with the vibriocidal
antibody (Spearman’s rank correlation coefficient, r=0.20,
P=0.004, and r=0.35, P,0.0001, respectively for TcpA and
LPS) and than were anti-CTB-IgA antibodies (r=0.06, P=0.23),
and anti-TcpA and anti-LPS IgA antibody levels were not
predictive of susceptibility to V. cholerae O1 independently of the
vibriocidal antibody titer.
Because baseline TCP-IgA was the only significant predictor of
susceptibility to V. cholerae O139 and there were a smaller number
of observations, a separate multivariate assessment was not feasible
for the O139 serogroup.
Nutritional markers and probability of infection with V.
cholerae
We evaluated the association between anthropometric markers
of nutritional status and susceptibility to infection with V. cholerae in
children younger than 5 years of age. Height- and weight-for-age
were not significantly associated with likelihood of V. cholerae
infection or symptomatic disease in young children exposed in the
household (Table 4).
To explore the relationship between micronutrient levels and
susceptibility to cholera, we also evaluated baseline zinc and
retinol levels in a subset of 278 household contacts (including a
total of 55 retinol and 129 zinc deficient individuals). Our
evaluation was restricted to contacts of patients with V. cholerae O1.
Zinc deficiency (defined at serum zinc #70 mg/dL [22]) was not
significantly associated with likelihood of infection with V. cholerae
O1 or with development of diarrhea. Retinol deficiency (defined as
serum retinol #20 mg/dL [22]) was associated with a higher risk
Table 1. Outcomes in 944 Household Contacts Completing 21 Days of Follow-up
Category
Number of
Contacts
Positive rectal swab
culture
4-fold increase in
vibriocidal
Symptomatic
(diarrhea)
Definite Infection
a N=202 Symptomatic 88 Yes Yes Yes
39 Yes No Yes
Asymptomatic 38 Yes Yes No
37 Yes No No
Possible Infection N=320 39 No Yes Yes
48 No Yes No
2 3 3 N oN oY e s
No evidence of Infection
a N = 4 2 2 4 2 2 N oN oN o
aOur primary analysis compared household contacts with definite infection, defined a positive rectal swab culture during the 21 days of follow-up, with those with no
evidence of infection.
doi:10.1371/journal.pntd.0000221.t001
Susceptibility to Vibrio cholerae
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deficiency was associated with a higher likelihood of developing
symptomatic disease if infected: all 9 of the retinol deficient
individuals infected with V. cholerae O1 developed symptomatic
disease, while only 14 of the 27 retinol replete infected individuals
developed symptomatic infection (P=0.05).
Genetic factors
Consistent with what was previously described in a earlier subset
of the current cohort [23], we found that individuals with blood
group O were less likely to become infected with V. cholerae O1
than non-blood group O individuals (OR 0.54, 95% CI 0.35–0.83,
Table 4), but if infected, had greater than twice the odds of
developing symptomatic infection (OR 2.13, P=0.035, 95% CI
1.05–4.33). There was no significant difference in the susceptibility
of individuals with blood group O to infection with V. cholerae
O139, although individuals with blood group O were more likely
to develop symptomatic disease if infected with either serogroup.
Because we hypothesized that additional host genetic factors
might contribute to susceptibility to cholera, we collected pedigree
Figure 1. The total proportion of household contacts with definite V. cholerae infection by age group. The red-hatched area indicates
those with symptomatic infection, the blue-hatched area indicates those with asymptomatic infection. The associated curves represent the predicted
likelihood of developing infection by age based on logistic regression modeling. Figure 1A shows the likelihood of V. cholerae O1 infection by age
bound in deciles (P for predicted model ,0.0001). 1B shows the likelihood of developing V. cholerae O139 infection according to age bound in
quintiles (P for predicted model=0.6).
doi:10.1371/journal.pntd.0000221.g001
Susceptibility to Vibrio cholerae
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in 2003). A total of 259 household contacts that completed 21 days
of follow-up were classified based on relatedness to the index case.
The analysis included 197 first-degree relatives (i.e. siblings,
parents or children) of the index case, and 62 non-first degree
relatives. Among this population, individuals who were first-degree
relatives of the index case had significantly greater odds of being
infected with V. cholerae compared to non-related or less closely
related contacts in the same household (OR [crude] 2.90, P=0.03,
95% CI 1.12–7.52, Table 4). This finding was independent of
blood group phenotype and age in a multivariate analysis (OR
[adjusted] 2.91, P=0.03, 95% CI 1.11–7.61).
Microbiologic and environmental factors
Household contacts of index patients infected with V. cholerae
O139 were more likely to become infected than contacts of
patients with V. cholerae O1 (OR 1.67, p=0.015, 95% CI 1.10–
2.52). There was no difference in the likelihood of infection
between contacts of index patients infected with Inaba (N=466)
versus the Ogawa (N=366) serotypes of V. cholerae O1 (OR 0.95,
p=0.86, 95%% CI 0.60–1.53).
In addition to intrinsic host and microbiologic characteristics,
other environmental factors might influence the outcome of
exposure to V. cholerae within a household. We found that attack
rates were markedly higher in individuals living in households that
included more than one infected individual (OR 5.50, P,0.001,
95% CI 3.18–9.51). This finding was independent of baseline
vibriocidal antibody titers of household contacts, suggesting that
variability in risk of infection in households may be due to a
common environmental risk and/or common genetic factors
influencing household susceptibility.
Discussion
An improved understanding of factors that influence host
susceptibility to cholera may aid in the development and
implementation of an effective vaccination program. In this study,
we identified novel immunologic markers that predict protection
from V. cholerae infection in a population in Bangladesh, as well as
other host characteristics that modify susceptibility.
Table 2. Immunologic correlates of protection from infection with V. cholerae in household contacts
Immunologic
Marker Serogroup
Mean Baseline Antibody
Levels (6SE)
a Crude Odds of V. cholerae
infection per doubling
b P 95% CI
Infected Not-infected
N=94 N=383
Vibriocidal All 5.1 (60.31) 6.6 (60.15) 0.84 ,0.001 0.77 0.93
O1 5.7 (60.36) 7.1 (60.14) 0.82 0.001 0.74 0.92
O139 3.6 (60.42) 3.8 (60.32) 0.97 0.7 (NS) 0.82 1.15
CTB-IgA All 3.5 (60.14) 4.1 (60.07) 0.74 0.002 0.60 0.90
O1 3.5 (60.16) 4.1 (60.08) 0.74 0.003 0.60 0.90
O139 3.4 (60.33) 4.2 (60.19) 0.74 0.15 (NS) 0.49 1.12
LPS-IgA All 3.8 (60.15) 4.2 (60.06) 0.76 0.009 0.62 0.93
O1 3.6 (60.19) 4.2 (60.07) 0.70 0.007 0.54 0.91
O139 4.3 (60.16) 4.4 (60.15) 0.91 0.6 (NS) 0.62 1.34
TcpA-IgA All 3.6 (60.10) 4.0 (60.06) 0.65 0.002 0.49 0.85
O1 3.5 (60.15) 3.9 (60.06) 0.65 0.015 0.46 0.92
O139 3.8 (60.10) 4.2 (60.10) 0.58 0.038 0.34 0.97
CTB-IgG All 6.2 (60.11) 6.4 (60.06) 0.84 0.24 (NS) 0.64 1.12
O1 6.5 (60.11) 6.6 (60.06) 0.93 0.56 (NS) 0.73 1.18
O139 6.1 (60.29) 6.6 (60.13) 0.77 0.20 (NS) 0.37 1.23
LPS-IgG All 6.1 (60.10 ) 6.2 (60.05) 0.88 0.30 (NS) 0.68 1.12
O1 6.1 (60.13) 6.2 (60.05) 0.88 0.35 (NS) 0.66 1.16
O139 6.2 (60.19) 6.3 (60.11) 0.83 0.52 (NS) 0.46 1.48
TcpA-IgG All 5.3 (60.08) 5.4 (60.04) 1.07 0.65 (NS) 0.80 1.40
O1 5.3 (60.10) 5.4 (60.04) 1.05 0.75 (NS) 0.76 1.47
O139 5.2 (60.10) 5.4 (60.08) 0.74 0.48 (NS) 0.31 1.72
aBaseline measurements are shown as log2 transformed antibody titer (vibriocidal) or relative kinetic ELISA values. The standard error of each mean is noted in
parentheses.
bAdjusted only for clustering by household.
doi:10.1371/journal.pntd.0000221.t002
Table 3. A multivariate logistic regression model of
predictors of protection from infection with V. cholerae O1 El
Tor in household contacts
Variable Adjusted OR 95% CI P
Age 0.98
a 0.97 1.00 0.02
Vibriocidal 0.86
b 0.77 0.96 0.007
CTB-IgA 0.79
b 0.66 0.95 0.01
aPer year of increasing age.
bPer each doubling of antibody titer.
doi:10.1371/journal.pntd.0000221.t003
Susceptibility to Vibrio cholerae
www.plosntds.org 6 April 2008 | Volume 2 | Issue 4 | e221The vibriocidal antibody is the only previously described
marker of immunity to cholera and is routinely utilized in pilot
studies of vaccine efficacy. Here, we show that levels of serum IgA
specific to three V. cholerae antigens – CTB, LPS and TcpA – also
predict protection among household contacts of patients infected
with V. cholerae O1 El Tor, the current predominant cause of
cholera. Interestingly, levels of serum IgG directed against these
same antigens did not predict protection, possibly because serum
IgA levels better reflect protective immune responses at the
intestinal mucosal surface where secretory IgA (sIgA) is the
predominant immunoglobulin. We also examined baseline fecal
levels of V. cholerae antigen specific IgA, although there was no
significant correlation of these with baseline serum IgA antibodies
to the same antigen. Antigen-specific fecal IgA levels did not
correlate with protection from cholera, except for a mild effect of
fecal IgA specific to LPS. This might reflect proteolysis of IgA in
fecal samples, such that baseline fecal IgA measurement may not
adequately represent an accurate level of the response to V. cholerae
antigens at the mucosal level.
Among the antigens evaluated, responses to TcpA appear to be
unique in that they are associated with protection from both
the O1 and O139 serogroups. Expression of tcpA mRNA is highly
up-regulated in V. cholerae during human infection [24], yet it
remains uncertain to what extent this antigen is present in current
killed and live-oral cholera vaccines. A systematic comparison of
TcpA responses in naturally-infected individuals compared to
vaccine recipients would be important to address this question.
Our data suggest that inclusion of TcpA as a vaccine component
may be useful in boosting protective immunity across both
serogroups.
Studies in the rabbit ileal loop model of cholera suggest that
anti-toxin and anti-LPS immune responses are synergistic in the
prevention of fluid accumulation [25]. In concordance with this
observation, our multivariate analysis showed that both anti-toxin
(anti-CTB) and anti-bacterial (vibriocidal antibody) responses were
independent predictors of susceptibility to cholera. This finding is
also consistent with the results of clinical trials of the whole cell-B
subunit vaccine, which suggest a role for anti-CTB responses in
conferring additional short term protection compared with whole
cell vaccine alone [9]. Our multivariate model also indicated that
increasing age predicted immunity from cholera, independent of
both anti-CTB IgA and vibriocidal antibody levels, suggesting
that additional components of protective immunity remain
unidentified.
In addition to adaptive immune responses, we identified other
host and environmental characteristics that affected the risk of
developing cholera in our study population. Although an
association between blood group phenotype and severity of
cholera has previously been recognized, we observed an additional
familial segregation of susceptibility to cholera within households.
In particular, first-degree relatives of cholera patients were
significantly more likely to develop infection with V. cholerae than
less closely related members living in the same household, and this
was independent of blood group. Such increased susceptibility
might be related to closer contact or shared behaviors between first
degree relatives, or could reflect additional genetic components of
susceptibility to cholera.
We found direct evidence to support the importance of nutrition
in susceptibility to infection with V. cholerae. Increasing levels of
retinol, but not zinc, were associated with decreased susceptibility
to both infection and symptomatic disease. This observation
underscores the importance of retinol supplementation in young
children in developing countries where cholera is endemic.
Our study has a number of limitations. Although we
demonstrated that cholera antigen-specific serum IgA levels
correlate with protection from infection with V. cholerae,i ti s
possible that these immunologic markers, like the vibriocidal
antibody, are surrogates for protective immune responses localized
at the mucosal surface. Thus, the inability to measure intestinal
levels of sIgA using non-invasive techniques remains a major
limitation and necessitates the discovery of better proxy measure-
ments of mucosal immunity. It is also possible that a portion of
household contacts in our study were infected prior to onset of
symptoms of the recognized household index case. We accounted
for this by excluding from assessment of baseline immunologic
characteristics those contacts reporting diarrhea in the week prior
to enrollment or having a positive rectal swab upon entry into the
study.
Taken together, our data suggest that immunologic, genetic,
and nutritional characteristics of individuals all contribute to
human susceptibility to infection with V. cholerae in a household.
Although it is hypothesized that immune responses at the mucosal
surface are the primary mediators of protection from V. cholerae,
the specific antigens to which these responses are directed have not
been identified. Our observation that levels of serum IgA (but not
serum IgG) directed at certain V. cholerae antigens are associated
with protection from infection underscores the need to better
understand anti-V. cholerae immunity at the mucosal surface. Such
understanding would be critical in designing and evaluating
improved vaccines against V. cholerae.
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Table 4. Other non-immunologic predictors of susceptibility
to infection with V. cholerae O1 El Tor in household contacts
Characteristic
Crude Odds Ratio
of V. cholerae O1
infection P 95% CI
Significant predictors
Retinol Deficient 2.36 0.05 1.00 5.53
Blood Group O 0.54 0.005 0.35 0.83
First Degree Relative of Case
a 2.90 0.03 1.12 7.52
Non-predictive
Zinc Deficient 1.02 0.97 0.28 3.7
Height for Age (Z) 0.88 0.30 0.68 1.12
Weight for Age (Z) 0.78 0.30 0.50 1.24
Weight for Height (Z) 0.88 0.66 0.49 1.57
aCompared to household contacts that were not first degree relatives.
doi:10.1371/journal.pntd.0000221.t004
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